Wearable Health Data: Physician Support vs. Integration Challenges

A recent survey conducted by the American Medical Association (AMA) highlights that while physicians recognize the potential of wearable devices to enhance patient care, significant challenges remain in integrating this data into routine clinical practice. According to the survey of over 2,000 physicians from six countries—namely the United States, Canada, the United Kingdom, France, Germany, and Spain—97% reported having reviewed wearable data in some form, and a significant majority believe it provides clinical advantages for patient management. Only a small percentage, 3%, indicated they never engage with such data.

The types of data most frequently reviewed by physicians across these countries include metrics related to heart physiology, general activity and function, biometrics and physical alerts, along with sleep patterns. In the U.S., 77% of physicians noted some clinical benefits from wearable data, with 74% of their non-U.S. counterparts echoing similar sentiments. Furthermore, the study indicated that 82% of physicians personally use wearable technology themselves, underscoring a strong endorsement from providers.

Despite this enthusiasm for wearable technology, the survey findings suggest that the current healthcare infrastructure is not adequately prepared to leverage this data to its full potential. John Whyte, M.D., CEO of AMA, remarked that the technology appears to have outpaced the healthcare system rather than the physicians themselves. According to him, existing systems are not structured to optimize the clinical impact of this data, highlighting the need for actionable data instead of merely having access to it.

To facilitate broader application of wearable data in clinical practice, several factors must be addressed. These include the necessity for stronger clinical validation of the data, clearer reimbursement frameworks, improved interpretative tools, and workflows that seamlessly integrate wearable data into the daily routines of healthcare providers. Willie Underwood III, M.D., AMA President, stated that when patients request their doctors to scrutinize their wearable data, physicians typically do respond positively—a testament to patient demand being a central driver for closing the gap between exposure to and effective use of wearable data.

The survey also shows that integration varies across different countries. For instance, fewer than 6% of physicians incorporate wearable data into their practice workflows. This inconsistency in adoption appears more closely correlated with factors like reimbursement policies, practical workflow feasibility, and regulatory conditions, rather than a lack of interest from physicians themselves. Notably, Germany and Spain emerged with the most promising forecasts regarding the integration of wearable data, while Canada and the U.K. reported lower readiness among their physicians.

In the U.S., the Current Procedural Terminology (CPT) codes that govern remote patient monitoring do not cover consumer-grade wearables, limiting reimbursement options for physicians reviewing this type of data. Consequently, the availability of reimbursement pathways significantly affects how often physicians engage with wearable data. The survey revealed that when such pathways exist, as seen in Germany with its DiGA pathway, healthcare providers are more likely to review wearable data in comparison to settings where no reimbursement avenues are available.

Yet, reimbursement is not the only factor influencing adoption. Legal liability concerns and the clinical readiness of providers also play crucial roles. In France, although reimbursement pathways exist, integration remains low due to physician apprehension about liability risks. Conversely, Germany, with a well-established reimbursement structure, exhibits high levels of feasibility and confidence among physicians concerning wearable data.

Addressing the variability in physicians' interactions with such data, cardiologists and endocrinologists showed the highest levels of engagement, while specialties such as primary care, neurology, and pulmonology expressed concerns about the relevance, reliability, and practicality of using wearable data.

The survey further investigated elements such as trust in regulatory standards and the availability of clinical evidence. Approximately half of the respondents indicated that regulatory approval heavily influences their confidence in integrating wearable data. Contrary to this, the survey revealed that regulatory clearance alone does not guarantee the effective incorporation of this data into clinical practice. Physicians noted that trust in the data, applicable clinical skills, and implementation issues were crucial aspects impacting whether they utilized wearables in their workflows.

The survey highlighted that randomized controlled trials (RCTs) and peer-reviewed studies are the most valued sources of confidence among physicians, with around 60% prioritizing these forms of evidence. To maximize the potential of wearables in healthcare, stakeholders, including health information technology vendors and electronic health record (EHR) systems, must enhance the integration of wearable data into medical records. According to Whyte, tech companies and clinicians need to collaborate on how to best incorporate this data while ensuring a smooth clinical workflow.

Physicians see wearables as a means of continuous data collection—an advantage over the traditional approach of sporadic office visits. Utilizing such data can significantly enhance clinical information, particularly in fields like cardiology, contributing to better disease management.

The AMA report also provides actionable recommendations aimed at bridging the gap in the integration of wearable data. Physicians should focus on algorithms with demonstrated clinical validation and advocate for the workflow structures that allow for systematic data review during patient visits. They are encouraged to engage with patients about potential false-positive or false-negative results, setting appropriate expectations regarding when clinical action will be taken, thus alleviating patient anxiety.

Establishing thorough documentation practices for instances when wearable data informs clinical decisions could also enhance legal liability management, which appeared as a prominent concern for U.S. physicians in the survey.

Policymakers are urged to develop distinct billing codes that allow for the in-visit evaluation of consumer wearable data, thus separating it from remote monitoring of devices prescribed by clinicians. Moreover, they should work on creating regulatory frameworks that foster trust in health data while incorporating privacy and security protections. Earlier this year, the FDA relaxed regulatory barriers for general wellness devices.

For U.S. regulators, it is crucial to clarify the applicability of existing CPT codes regarding consumer wearable data review. Furthermore, medical device manufacturers are encouraged to bolster their credibility through robust evidence. This includes publishing specialty-specific algorithm accuracy reports and providing transparent access to validation datasets to build clinician trust.

In conclusion, the integration of wearable data into healthcare continues to face significant roadblocks, although there is undeniable interest among physicians. Addressing the systemic challenges—ranging from reimbursement pathways to regulatory trust—and fostering clinician-patient engagement will be essential for realizing the full potential of wearable technology in improving healthcare outcomes.